Population Health

Vaccine safety and effectiveness are patients’ biggest concerns about a potential coronavirus disease 2019 (COVID-19) vaccine, says Maura Abbott, PhD, AOCNP, CPNP, RN, assistant professor of nursing at the Columbia University School of Nursing.

The authors used health care claims and survey data to identify a strategy that might promote life satisfaction while advancing equity in an insured population.

To mark the 25th anniversary of the journal, each issue in 2020 will include a special feature: an interview with a thought leader in the world of health care and medicine. The September issue features a conversation with Georges C. Benjamin, MD, executive director of the American Public Health Association.

Transitioning from population to precision health care, as well as eschewing old health care models of the past linked with misuse and excess cost, can assist in evolving the current US health care delivery system.

Nineteen bioethicists proposed a 3-phase plan for equitable distribution of a vaccine for coronavirus disease 2019 (COVID-19).

In this episode of Managed Care Cast, we talk with Michael N. Abrams, a cofounder and managing partner of Numerof & Associates, about the fifth annual report on the state of population health.

Preliminary data find Moderna's COVID-19 vaccine effective in older adults; FDA authorizes use of $5 COVID-19 rapid test; the DOJ asks for nursing home data from 4 blue states.

Two days after the CDC changed its guidance on who should get tested for SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), HHS said the move was not politically motivated.

Until a vaccine is available, antibody tests may offer the best way to assess risk prevalence and community spread of COVID-19.

Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases, spoke recently with The American Journal of Managed Care®. During the interview, we asked about health burdens that disproportionately affect Black and other multiracial US communities.

In this episode of Managed Care Cast, we share a little bit of our forthcoming interview with Georges C. Benjamin, MD, executive director of the American Public Health Association, which will appear in the September issue of The American Journal of Managed Care®.

A move by HHS to allow pharmacists to give childhood vaccinations draws criticism from the American Academy of Pediatrics.

Through the partnership between Innovaccer and Emtiro Health, data utilization will work to delineate and address social aspects known to affect the health of populations nationwide, said Kelly Garrison, CEO at Emtiro Health, and Paul Grundy, MD, chief transformation officer at Innovaccer.

Patricia Salber, MD, MBA, of The Doctor Weighs In, and Scott Hayworth, MD, president and CEO of New York-based CareMount Medical, discuss delivering preventive care and managing chronic illnesses during the coronavirus disease 2019 (COVID-19) pandemic.

When a crisis hits and members become isolated, how can a health plan continue to play an active role in maintaining their health?

AJMC interviews Jill A. Fisher, PhD, author of a new book, Adverse Events: Race, Inequality, and the Testing of New Pharmaceuticals. Her research took her inside clinical testing sites for phase 1 drug studies.

From 1968 to 2016, differences among Black and White older adults’ mortality rates have narrowed in urban areas of America. However, data show a considerable widening in the mortality rate among Black and White men living in rural counties.

Robin Gelburd, JD, president of FAIR Health, discusses telehealth growth in May medical claims.

The coronavirus disease 2019 (COVID-19) vaccines that are leading the pack are utilizing a new vaccine technology that has never been approved for human use by the FDA. As a result, there are a lot of unknowns.

All patients with cancer deserve a fair shot at survival, and this includes access to clinical trials. At present, however, access to these trials is restricted under Medicaid coverage, necessitating a need for change at the federal policy level, noted Fumiko Chino, MD, assistant attending radiation oncologist at Memorial Sloan Kettering Cancer Center in New York, in an interview for ASCO20 Virtual, this year’s annual meeting of the American Society of Clinical Oncology.

Through the partnership, Humana and Heal will expand the startup’s current markets to include Chicago, Charlotte, Houston and others that are part of Bold Goal, a multi-year effort to improve overall health of communities by addressing both medical needs and working with partners to address social determinants of health, such as food insecurity.

On this episode of Managed Care Cast, we speak with the senior vice president of Network Payment Innovation and Contract Management for Blue Cross Blue Shield of Massachusetts, which is launching a new value-based payment approach for independent primary care practices. The pilot project will reward practices for keeping patients healthy while providing extra support during the pandemic.

Pandemic anxiety continues to hurt Americans' mental health, while concerns about the impact of coronavirus disease 2019 (COVID-19) splits by party affiliation and background.

On today’s episode of Managed Care Cast, we feature a short excerpt of an upcoming interview in the August issue of The American Journal of Managed Care® with Mandy K. Cohen, MD, MPH, North Carolina's secretary of the Department of Health and Human Services, as part of our yearlong Q&A series. We discussed the state's upcoming transition to Medicaid managed care, the pandemic, her advice to public health workers in the face of criticism, and how what is learned from the pandemic can help inform the future of managed care going forward.

Two experimental vaccines, one from AstraZeneca and the other from CanSino Biologics, have shown promising results against coronavirus disease 2019 (COVID-19) in a phase 1/2 trial and a phase 2 trial. Results for both were published in The Lancet.

The attorneys general who spoke about the suit—California’s Xavier Becerra, Massachusetts’ Maura Healey, and New York’s Leticia James—said they found it difficult to believe that the administration would adopt the rule in the midst of the coronavirus disease 2019, which is disproportionately affecting communities of color.

The talk by Ned Sharpless, MD, director of the National Cancer Institute, preceded presentations on some of the earliest findings about the effects of COVID-19 on cancer: It appears that patients treated with chemotherapy for lung or thoracic cancer shortly before being diagnosed with COVID-19 face a higher risk of death, and so do patients with cancer who take the combination of hydroxychloroquine (HCQ) and azithromycin.

Following an announcement that hospitals are to bypass the CDC and send all coronavirus disease 2019 (COVID-19)–related information to a central database, questions have been raised as to the future of COVID-19 data transparency and politicization.

Between 2002 and 2015, data showed an increase in the percentage of intimate partner violence (IPV)–related emergency department claims paid by private insurance in the United States. This finding suggests the Affordable Care Act (ACA) may have increased women’s willingness and ability to seek medical attention for IPV-related injuries and disclose IPV as the source of the injuries, according to a study published in Women’s Health Issues.

The explosive growth of telehealth seen in March 2020 continued unabated in April, claims data show.